Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct 5;28(10):420-427.
doi: 10.2188/jea.JE20170103. Epub 2018 Feb 24.

Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan

Affiliations

Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan

Akiyo Yoshimura et al. J Epidemiol. .

Abstract

Background: Recent improvements in 5-year survival of breast cancer have been reported in Japan and other countries. Though the number of long-term breast cancer survivors has been increasing, recent improvements in 10-year survival have not been reported. Moreover, the degree of improvement according to age and disease stage remains unclear.

Methods: We calculated long-term survival using data on breast cancer diagnosed from 1993 through 2006 from six prefectural population-based cancer registries in Japan. The recent increase in 10-year relative survival was assessed by comparing the results of period analysis in 2002-2006 with the results of cohort analysis in 1993-1997. We also conducted stratified analyses by age group (15-34, 35-49, 50-69, and 70-99 years) and disease stage (localized, regional, and distant).

Results: A total of 63,348 patients were analysed. Ten-year relative survival improved by 2.4% (76.9% vs 79.3%) from 1993 through 2006. By age and stage, 10-year relative survival clearly improved in the age 35-49 years (+2.9%; 78.1% vs 81.0%), 50-69 years (+2.8%; 75.2% vs 78.0%) and regional disease (+3.4%; 64.9% vs 68.3%). In contrast, the degree of improvement was small in the age 15-34 years (+0.1%; 68.2% vs 68.3%), 70-99 years (+1.0%; 87.6% vs 88.6%), localized disease (+1.1%; 92.6% vs 93.7%) and distant metastasis (+0.9%; 13.8% vs 14.7%).

Conclusions: These population-based cancer registry data show that 10-year relative survival improved 2.4% over this period in Japan. By age and stage, improvement in the age 15-34 years and distant metastasis was very small, which suggests the need for new therapeutic strategies in these patients.

Keywords: breast cancer; cancer registration; long-term survival; period analysis; relative survival.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Analysed patient data
Figure 2.
Figure 2.. Relative survival of patients with breast cancer by period
Figure 3.
Figure 3.. Relative survival of patients with breast cancer by age group
Figure 4.
Figure 4.. Relative survival of patients with breast cancer by disease stage

References

    1. Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H; Japan Cancer Surveillance Research Group . Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–891. 10.1093/jjco/hyv088 - DOI - PubMed
    1. Cancer Information Service NCC, Japan. Cancer Statistics White Papar 2012. 2012.
    1. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, Sobue T; Research Group of Population-Based Cancer Registries of Japan . Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol. 2011;41:40–51. 10.1093/jjco/hyq167 - DOI - PubMed
    1. Cancer Information Service NCC, Japan. Monitoring of Cancer Incidence in Japan—Survival 2006–2008 Report. 2016.
    1. Holleczek B, Brenner H. Trends of population-based breast cancer survival in Germany and the US: decreasing discrepancies, but persistent survival gap of elderly patients in Germany. BMC Cancer. 2012;12:317. 10.1186/1471-2407-12-317 - DOI - PMC - PubMed